Publication

FISH AND CRUSTACEANS: IMMUNE SYSTEM, VACCINE DEVELOPMENT AND IMPLICATIONS


Chong, C.M. and Maha, A., 2014. Fish and Crustaceans: Immune System, Vaccine Development and Implications. Perspective of Fisheries and Aquaculture in Malaysia. Universiti Putra Malaysia Press, Selangor, pp.188-207.

View Article
Introduction

Fish are phylogenetically the first animal phylum to evolve adaptive immune responses in their defensive mechanisms (Magnadottir, 2010). Fish are an extremely diverse group comprising jawless vertebrates (e.g. lampreys and hagfish), cartilaginous fishes (e.g. sharks and rays) and teleost/bony fishes. However, their immune system is viewed to be not as advanced compared to mammals.

Conversely, crustaceans are invertebrates lacking adaptive immunity with only innate immune system. Several interesting questions concerning modern evolutionary theory can be asked: How do these animals with relatively less advanced immune system survive in aquatic habitats laden with microbes which potentially expose them to infectious diseases? Recent studies showed that crustaceans previsously exposed to weakened microbes can develop enhanced immunity and react more effectively to subsequent challenges of the same pathogen (Rodríguez and Le Moullac, 2000; Witteveldt et al., 2004a; Witteveldt et al., 2004b; Johnson et al., 2008; Li et al., 2008; Rowley and Pope, 2011). How is this achieved in crustaceans without an adaptive immune system with immunological memory?

The bookchapter covers the differences in the defensive mechanisms of fish (with the emphasis on teleost fish) and crustaceans, in particular on the immune system with inference to the discussion on probable evolutionary reasons and the implications on vaccine development.

Publication

Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn


Chen-Fei, L., Chou-Min, C. and Jiun-Yan, L., 2020. Feasibility of vaccination against Macrobrachium rosenbergii nodavirus infection in giant freshwater prawn. Fish & shellfish immunology.

View Article
Abstract

The giant freshwater prawn/giant river prawn, Macrobrachium rosenbergii is one of the high market value crustaceans cultured worldwide. The intensified aquaculture of the species has led to the outbreak of infectious diseases, prominently, the white tail disease (WTD). It is caused by the infection of Macrobrachium rosenbergii nodavirus (MrNV), which was classified in the family of Nodaviridae. To-date, there are no effective prophylactic and therapeutic agents available against MrNV infection. Vaccination is known to be the most effective prophylactic agent in disease prevention. However, vaccine development against virus infection in crustaceans is equivocal. The feasibility of vaccination in conferring immune protection in crustaceans against infectious diseases is disputable. The argument lies in the fact that crustaceans do not possess adaptive immunity, which is the main immune component that functions to establish immunological memory upon vaccination. Nevertheless, an increasing number of literatures has been documented, which concerns the development of vaccines against infectious diseases in crustaceans. The current review deliberates different approaches in vaccine development against MrNV, which were documented in the past years. It is noteworthy that the live-attenuated MrNV vaccine has not been experimented by far. Thus, the potential of live-attenuated MrNV vaccine in conferring long-term immune protection through the establishment of innate immune memory is currently being discussed.